EUVIMEDEUVIMED entdecken
Open Access

International Network for Sinonasal Cancer Research: a collaborative group to advance research and clinical trials for rare sinonasal malignancies

Nyall R London iD, Glenn J Hanna, Neal S Akhave iD, Garret Choby, Lot A Devriese, François R Ferrand iD, Gary L Gallia, Lifeng Li, Antoine Moya-Plana, Umar Rehman, Teppei Takeda, Juliette Thariat iD und 3 weitere

JNCI: Journal of the National Cancer Institute · 01.11.2026 · 118 (11) · 2007-2014

DOI: 10.1093/jnci/djaf366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 17.12.2025. Verfasst von Nyall R London und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sinonasal and Skull Base Tumor Section, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Heal…. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms, Rare Diseases, Nose Neoplasms, Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute, U.S. Department of Health and Human Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of evidence-based treatment recommendations for rare cancers is challenging due to limited funding opportunities, spread of small numbers of patients across multiple institutions, and other obstacles. Malignancies of the sinonasal cavity are particularly rare with an overall incidence of ∼0.56 cases per 100 000 population per year. Additionally, clinical behavior varies with a reported 5-year overall survival rate ranging from 22% to 67%. Here we describe our initial efforts including formation of an international network dedicated to sinonasal cancer research and highlight keys for successful study of rare tumors. This network first began with large multi-institutional retrospective collaborations of rare sinonasal tumors leading to improvements in staging for olfactory neuroblastoma and sinonasal melanoma. These efforts have been followed by a new emphasis on development of collaborative interventional trials as well as the development of position statements and recommendations to guide use of emerging molecularly targeted therapies. In order to be successful in studying rare malignancies, collaboration and teamwork is key along with an unrelenting drive for development of evidence to help guide treatment for rare cancers. This manuscript serves as an outline that may be applied by other interested groups to improve the study of other tumors in the human body.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paranasal Sinus NeoplasmsRare DiseasesNose NeoplasmsMelanomaBiomedical ResearchHumansClinical Trials as TopicEsthesioneuroblastoma, OlfactoryNeoplasm StagingInternational Cooperation

Autor:innen und Institutionen

  • Sinonasal and Skull Base Tumor Section, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  • Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

ORCID-Profile: Nyall R London, Neal S Akhave, François R Ferrand, Juliette Thariat, Robbie S R Woods

Förderung

  • Intramural Research Program of the National Institutes of Health
  • Center for Cancer Research, National Cancer Institute
  • U.S. Department of Health and Human Services
  • Head and Neck Cancer Research Fund
  • NIH

Zitieren

APA

London, N. R., Hanna, G. J., Akhave, N. S., Choby, G., Devriese, L. A., Ferrand, F. R., Gallia, G. L., Li, L., Moya-Plana, A., Rehman, U., Takeda, T., Thariat, J., Woods, R. S. R., Verillaud, B., & Lechner, M. (2026). International Network for Sinonasal Cancer Research: a collaborative group to advance research and clinical trials for rare sinonasal malignancies. JNCI: Journal of the National Cancer Institute, 118(11), 2007-2014. https://doi.org/10.1093/jnci/djaf366

Vancouver

London NR, Hanna GJ, Akhave NS, Choby G, Devriese LA, Ferrand FR, et al. International Network for Sinonasal Cancer Research: a collaborative group to advance research and clinical trials for rare sinonasal malignancies. JNCI: Journal of the National Cancer Institute. 2026;118(11):2007-2014. doi:10.1093/jnci/djaf366

BibTeX
@article{London2026,
  author = {London, Nyall R and Hanna, Glenn J and Akhave, Neal S and Choby, Garret and Devriese, Lot A and Ferrand, François R and Gallia, Gary L and Li, Lifeng and Moya-Plana, Antoine and Rehman, Umar and Takeda, Teppei and Thariat, Juliette and Woods, Robbie S R and Verillaud, Benjamin and Lechner, Matt},
  title = {International Network for Sinonasal Cancer Research: a collaborative group to advance research and clinical trials for rare sinonasal malignancies},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  volume = {118},
  number = {11},
  pages = {2007--2014},
  doi = {10.1093/jnci/djaf366}
}
Kostenlos starten →